海普瑞(002399.SZ)拟向美国海普瑞增资不超6.9895亿元
格隆汇 7 月 31日丨海普瑞(002399.SZ)公布,Hepalink USA Inc.(“美国海普瑞”)系公司的全资子公司,投资额为约1.13亿美元。为了改善美国海普瑞的资产负债结构以降低其财务费用,并增强其作为公司海外投资平台的资本实力,公司拟以自有资金折合不超过人民币6.9895亿元增加对美国海普瑞的投资(根据2020年7月28日人民币兑美元汇率6.9895计算),此次增资完成后,美国海普瑞的投资总额将增加至不超过约2.13亿美元,仍为公司的全资子公司。
此次对美国海普瑞的增资主要是为了改善美国海普瑞的资产负债结构,降低其银行贷款的财务费用支出,并增加其未来的融资与投资能力,将进一步强化其作为公司海外投资业务发展和技术引进的平台作用。增资完成后,美国海普瑞仍为公司的全资子公司,不影响公司合并报表范围,对公司正常经营没有影响。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.